D-Index & Metrics Best Publications
Medicine
Germany
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 127 Citations 65,271 1,177 World Ranking 1589 National Ranking 76

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Germany Leader Award

Overview

What is he best known for?

The fields of study Stefan Zeuzem is best known for:

  • Cancer
  • Gene
  • Hepatitis C

His research brings together the fields of Adverse effect and Internal medicine. In his study, Stefan Zeuzem carries out multidisciplinary Virus and Hepatitis B virus research. His study deals with a combination of Hepatitis B virus and Virus. His study connects Cirrhosis and Gastroenterology. His research on Cirrhosis frequently connects to adjacent areas such as Gastroenterology. Stefan Zeuzem integrates many fields in his works, including Hepatitis C virus and Hepacivirus. He conducts interdisciplinary study in the fields of Hepacivirus and Hepatitis C virus through his research. He integrates Ribavirin and Telaprevir in his research. Telaprevir and Ribavirin are two areas of study in which he engages in interdisciplinary work.

His most cited work include:

  • Sorafenib in Advanced Hepatocellular Carcinoma (10664 citations)
  • Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C (2773 citations)
  • Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus (2260 citations)

What are the main themes of his work throughout his whole career to date

His Genetics research focuses on subjects like Gene, which are linked to Biochemistry and Genotype. Stefan Zeuzem carries out multidisciplinary research, doing studies in Biochemistry and Gene. He merges many fields, such as Genotype and Virus, in his writings. He performs multidisciplinary study in the fields of Virus and Viral load via his papers. In his papers, he integrates diverse fields, such as Internal medicine and Pathology. In his study, he carries out multidisciplinary Pathology and Internal medicine research. His Gastroenterology study frequently draws parallels with other fields, such as Cirrhosis. His Gastroenterology research extends to the thematically linked field of Cirrhosis. Stefan Zeuzem integrates many fields, such as Hepatitis C virus and Hepacivirus, in his works.

Stefan Zeuzem most often published in these fields:

  • Internal medicine (75.54%)
  • Virus (60.14%)
  • Gastroenterology (52.81%)

What were the highlights of his more recent work (between 2020-2022)?

  • Internal medicine (84.00%)
  • Gastroenterology (56.00%)
  • Virus (48.00%)

In recent works Stefan Zeuzem was focusing on the following fields of study:

As part of his studies on Internal medicine, Stefan Zeuzem often connects relevant areas like Adverse effect. His work on Gastroenterology is being expanded to include thematically relevant topics such as Portal hypertension. His research on Virus often connects related areas such as Chronic hepatitis. His multidisciplinary approach integrates Cirrhosis and Hepatocellular carcinoma in his work. Stefan Zeuzem combines Hepatocellular carcinoma and Cirrhosis in his research. His study on Virology is mostly dedicated to connecting different topics, such as Outbreak. As part of his studies on Outbreak, he often connects relevant subjects like Virology. His Hepatitis C virus study frequently links to adjacent areas such as Sofosbuvir. Stefan Zeuzem undertakes interdisciplinary study in the fields of Sofosbuvir and Ribavirin through his works.

Between 2020 and 2022, his most popular works were:

  • Impact of COVID-19 on global HCV elimination efforts (145 citations)
  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study (112 citations)
  • PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis (86 citations)

In his most recent research, the most cited works focused on:

  • Epidemiology
  • Hepatitis C
  • Virus

Hepatitis C virus, Hepatitis a virus and Hepatitis B virus are the areas that his Virus study falls under. Stefan Zeuzem brings together Hepatitis C virus and Hepatitis C to produce work in his papers. He integrates Hepatitis C with Viral hepatitis in his study. In his research, he undertakes multidisciplinary study on Viral hepatitis and Hepatitis B. His work often combines Hepatitis B and Hepatitis B virus studies. His Virus research extends to Hepatitis a virus, which is thematically connected. His research on Hepatitis A and Acute hepatitis is centered around Hepatitis. Stefan Zeuzem brings together Hepatitis A and Hepatitis to produce work in his papers. His Cohort study study spans across into areas like Prospective cohort study and Cohort.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard.
The New England Journal of Medicine (2008)

13939 Citations

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Hadziyannis Sj;Sette H;Morgan Tr;Balan.
Annals of Internal Medicine (2004)

3932 Citations

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

Thierry Poynard;Patrick Marcellin;Samuel S Lee;Christian Niederau.
The Lancet (1998)

3658 Citations

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie.
The New England Journal of Medicine (2011)

3191 Citations

Treatment of HCV Infection by Targeting MicroRNA

Harry L A Janssen;Hendrik W Reesink;Eric J Lawitz;Stefan Zeuzem.
The New England Journal of Medicine (2013)

2281 Citations

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Bruce R. Bacon;Stuart C. Gordon;Eric Lawitz;Patrick Marcellin.
The New England Journal of Medicine (2011)

2199 Citations

Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis

Richard Moreau;Rajiv Jalan;Pere Gines;Marco Pavesi.
Gastroenterology (2013)

2178 Citations

Telaprevir for retreatment of HCV infection.

Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz.
The New England Journal of Medicine (2011)

2079 Citations

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier.
The New England Journal of Medicine (2014)

2026 Citations

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection European Association for the Study of the Liver ⇑

Markus Peck;Antonio Craxi;Michael Fried;Stefan Zeuzem.
(2013)

1755 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stefan Zeuzem

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 221

Jean-Michel Pawlotsky

Jean-Michel Pawlotsky

Université Paris Cité

Publications: 219

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 204

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 202

Josep M. Llovet

Josep M. Llovet

University of Barcelona

Publications: 195

Kazuaki Chayama

Kazuaki Chayama

Hiroshima University

Publications: 190

Masatoshi Kudo

Masatoshi Kudo

Kindai University

Publications: 184

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 183

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 177

Hiromitsu Kumada

Hiromitsu Kumada

Fukuoka University

Publications: 168

Maria Buti

Maria Buti

Instituto de Salud Carlos III

Publications: 162

Fabien Zoulim

Fabien Zoulim

Inserm

Publications: 161

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 159

Antonio Craxì

Antonio Craxì

University of Palermo

Publications: 157

Stanislas Pol

Stanislas Pol

Université Paris Cité

Publications: 151

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 149

Trending Scientists

Sennur Ulukus

Sennur Ulukus

University of Maryland, College Park

Zhen-Qing Chen

Zhen-Qing Chen

University of Washington

Isao Mochida

Isao Mochida

Kyushu University

Johji Yamahara

Johji Yamahara

Kyoto Pharmaceutical University

Guy Daculsi

Guy Daculsi

University of Nantes

Jan Jansa

Jan Jansa

Czech Academy of Sciences

Alan H. Fairlamb

Alan H. Fairlamb

University of Dundee

Charles B. Kimmel

Charles B. Kimmel

University of Oregon

Sylvie Robine

Sylvie Robine

Institute Curie

Tomohisa Ogawa

Tomohisa Ogawa

Tohoku University

Sean R. Cutler

Sean R. Cutler

University of California, Riverside

Eric Oswald

Eric Oswald

Federal University of Toulouse Midi-Pyrénées

Chih-An Huh

Chih-An Huh

Academia Sinica

Jeffrey E. Rubnitz

Jeffrey E. Rubnitz

St. Jude Children's Research Hospital

Carolyn S.P. Lam

Carolyn S.P. Lam

National University of Singapore

Something went wrong. Please try again later.